MIRA INFORM REPORT

 

 

Report No. :

343194

Report Date :

01.10.2015

 

IDENTIFICATION DETAILS

 

Name :

FARMATRADE SRL

 

 

Registered Office :

8 (Exazcuenaga) 4029 Villa Lynch  1672-Buenos Aires

 

 

Country :

Argentina

 

 

Date of Incorporation :

26.11.1990

 

 

Legal Form :

Limited company

 

 

Line of Business :

Distribution and export of pharmaceutical products.

 

 

No. of Employees :

17

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Small Company

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Exist

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Argentina

C1

C1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

ARGENTINA - ECONOMIC OVERVIEW

 

Argentina benefits from rich natural resources, a highly literate population, an export-oriented agricultural sector, and a diversified industrial base. Although one of the world's wealthiest countries 100 years ago, Argentina suffered during most of the 20th century from recurring economic crises, persistent fiscal and current account deficits, high inflation, mounting external debt, and capital flight.

A severe depression, growing public and external indebtedness, and an unprecedented bank run culminated in 2001 in the most serious economic, social, and political crisis in the country's turbulent history. Interim President Adolfo RODRIGUEZ SAA declared a default - at the time the largest ever - on the government's foreign debt in December of that year, and abruptly resigned only a few days after taking office. His successor, Eduardo DUHALDE, announced an end to the peso's decade-long 1-to-1 peg to the US dollar in early 2002. The economy bottomed out that year, with real GDP 18% smaller than in 1998 and almost 60% of Argentines under the poverty line. Real GDP rebounded to grow by an average 8.5% annually over the subsequent six years, taking advantage of previously idled industrial capacity and labor, an audacious debt restructuring and reduced debt burden, excellent international financial conditions, and expansionary monetary and fiscal policies. Inflation also increased, however, during the administration of President Nestor KIRCHNER, which responded with price restraints on businesses, as well as export taxes and restraints, and beginning in 2007, with understating inflation data.

Cristina FERNANDEZ DE KIRCHNER succeeded her husband as President in late 2007, and the rapid economic growth of previous years began to slow sharply the following year as government policies held back exports and the world economy fell into recession. The economy in 2010 rebounded strongly from the 2009 recession, but has slowed since late 2011 even as the government continued to rely on expansionary fiscal and monetary policies, which have kept inflation in the double digits.

The government expanded state intervention in the economy throughout 2012. In May 2012 the Congress approved the nationalization of the oil company YPF from Spain's Repsol. The government expanded formal and informal measures to restrict imports during the year, including a requirement for pre-registration and pre-approval of all imports. In July 2012 the government also further tightened currency controls in an effort to bolster foreign reserves and stem capital flight. In October 2013, the government settled long-standing international arbitral disputes dating back to before and following the 2001 Argentine financial crisis. During 2014, the government continued with expansionary fiscal and monetary policies and foreign exchange and imports controls. Between 2011 and 2013, Central Bank foreign reserves had dropped $21.3 billion from a high of $52.7 billion. In July 2014, Argentina and China agreed on an $11 billion currency swap; the Argentine Central Bank has received the equivalent of $3.2 billion in Chinese yuan, which it counts as international reserves.

In 2014, the government also took some measures to mend ties with the international financial community, including engaging with the IMF to improve its economic data reporting, reaching a compensation agreement with Repsol for the expropriation of YPF, and agreeing to pay $9.7 billion in arrears to the Paris Club over five years, including $606 million owed to the United States. In July 2014, Argentina made its first payment to Paris Club creditors since the country’s 2001 financial crisis. At the same time, the Argentine government in July 2014 entered a technical default on its external debt after it failed to reach an agreement with holdout creditors in the US. The government’s delay in reaching a settlement and the continuation of interventionist and populist policies are contributing to high inflation and a prolonged recession, according to private analysts.

 

Source : CIA


 

STATUTORY INFORMATION

Legal Name:

FARMATRADE SRL

Trade Name:

FARMATRADE 

CUIT:

30-64122177-1

Date Created:

1990

Date Incorporated:

26/11/1990

Legal Address:

8 (EXAZCUENAGA) 4029
VILLA LYNCH
1672-BUENOS AIRES

Operative Address:

8 (EXAZCUENAGA) 4029
VILLA LYNCH
1672-BUENOS AIRES

Telephone:

54 11 4753-7474

Fax:

54 11 4753-7474

Legal Form:

Limited company

Email:

info@farmatrade.com

Registered in:

AGENCIA NRO 15
CALLE 83 (YAPEYU) N° 2079
1650 BUENOS AIRES

Website:

www.farmatrade.com.ar

Contact:

Ricardo Alberto Ghiglione, Director

Staff:

17

Activity:

Pharmaceutical Industry

 

 

BANKS

According to Argentinian Central Bank, the company maintains credit lines with the following banks:

BANK

AMOUNT IN AR$

BANCO CREDICOOP COOPERATIVO LIMITADO

5824

AMERICAN EXPRESS ARGENTINA S.A.

148,7

BANCO DE GALICIA Y BUENOS AIRES S.A.

0,5

 

According to the classification of banking relations of Argentina, the company operates with level: 1.

This is the highest classification in the system. It means that the  company/person is fulfilling correctly its current Credit
obligations.

 

There are no rejected checks

 

 

History

 

 

Farmatrade was founded in 1990

 

 

PRINCIPAL ACTIVITY

 

 

The company is dedicated to the distribution and export of pharmaceutical products.

Products/Services description:

Pharmaceuticals
Medical Products

Brands:

FRAMATRADE

Sales are:

Wholesale

Clients:

QUIMFA S.A.
Paraguay

VICENTE SCAVONE & CIA.SA
Paraguay

BEL STAR S A
Colombia

PROTAMEEN CHEMICALS
USA

PROPHAR SA
Ecuador

Suppliers:

Alambic Limited
Grindlays Pharmaceuticals PVT. LTD.
Hubei Maxpharm Industries Co. Ltd.
Megafine Pharma P. Ltd.
Precise Chemipharma Pvt. Ltd.
SeQuent Scientific Limited.

Operations area:

National and International

The company imports from

Spain, India

The company exports to

Latin America

The subject employs

17 employees

Payments:

Regular-made on a 45 day basis

 

 

LOCATION

 

Headquarters :

8 (EXAZCUENAGA) 4029
VILLA LYNCH
1672-BUENOS AIRES

Branches:

The company does not have branches 

 

 

 

GROUP STRUCTURE AND SUBSIDIARY COMPANIES

 

Listed at the stock exchange:

NO

Capital:

$ 2.250.000

Shareholders:

Ricardo Alberto Ghiglione 50%
Adela Inés Alonso 50%

Management:

Ricardo Alberto Ghiglione, Director
Adela InéS Alonso, Director

 

 

 

 

FINANCIAL INFORMATION

 

 

 

This is a private company which does not make its financial public.

 

 

ARS 2014

 

Revenue

10 000 000

 

 

Exports FOB USD

 

2015

44.715

2014

86.432

2013

77.517

2012

127.301

2011

37.207

2010

40.974

 

 

LEGAL FILINGS

 

 

 

 

Public Record No. 1530246. For Scripture. 162 of 07.07.2015, Ini Diego Martin, head of seven hundred and fifty (750) social shares with a nominal value one thousand pesos ($ 1,000) each, sell, assign and transfer the its entire holding, as detailed below: the amount of three hundred seventy five (375) shares part Ricardo Alberto Ghiglione; and the amount of three hundred seventy five (375) shares part Agnes Adela Alonso.

 

 

 

 

SUMMARY

 

 

The company is dedicated to the distribution and export of pharmaceutical products.

 

It has 25 years of experience in the market with a small sized structure.

 

The company has various open credit lines with national banks and is also involved in export activities.

 

Its payment behaviour is good; according to the Central Bank of Argentina.

 

There are no negative connected to the subject. 

 

 

RISK INFORMATION

 

 

 

DEBTS

Controlled

PAYMENTS

No Complaints

CASH FLOW

Normal

STATUS

This Corporation is in Good Standing

 

 

INTERVIEW

 

NAME

Paula  

POSITION

Administrative 

COMMENTS

She confirmed owners, staff, activity and brands. 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.65.74

UK Pound

1

Rs.99.53

Euro

1

Rs.73.80

 

INFORMATION DETAILS

 

Analysis Done by :

KAS

 

 

Report Prepared by :

TRU

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.